Jager M J, Bradley D, Streilein J W
Department of Ophthalmology, AZL, Leiden, The Netherlands.
Transpl Immunol. 1995 Jun;3(2):135-42. doi: 10.1016/0966-3274(95)80040-9.
Corneal transplantations may survive when transplanted orthotopically even in the presence of massive corneal neovascularization, while such grafts would be rejected in heterotopic locations. Experiments with murine tissues have shown that cultured corneal tissue as well as iris/ciliary body (I/CB) tissue produce immunosuppressive factors. This was not the case when traumatized corneas were tested. We therefore wondered whether the same difference could be observed when explants of normal or pathological human corneas or I/CB tissues were tested. Supernatant of cultured cornea and I/CB tissue was added to a mixed lymphocyte reaction (BALB/c responder and C57B1/6 stimulator cells) and thymidine incorporation was measured. Culture supernatants from normal corneas and corneas with bullous keratopathy achieved similar levels of MLR inhibition, which could not be blocked by addition of anti-transforming-growth factor-beta 2 antibody or indomethacin. The supernatant from cultured I/CB cells from normal eyes and from eyes containing a posterior segment melanoma did not differ in their immunosuppressive effect. The MLR inhibitory effect of supernatant from I/CB cells was partly blocked by addition of indomethacin. We conclude that MLR inhibiting factors are produced by normal and pathological corneas and by I/CB cells, but the supernatants from these tissues achieve their effect by different means. It is likely that the ability of cornea and I/CB tissues to produce immunosuppressive factors contributes to the success of orthotopic corneal transplants in man.
角膜移植即使在存在大量角膜新生血管的情况下原位移植时也可能存活,而此类移植物在异位位置会被排斥。对鼠组织进行的实验表明,培养的角膜组织以及虹膜/睫状体(I/CB)组织会产生免疫抑制因子。但对受伤角膜进行测试时情况并非如此。因此,我们想知道当对正常或病理性人角膜或I/CB组织的外植体进行测试时,是否会观察到同样的差异。将培养的角膜和I/CB组织的上清液加入混合淋巴细胞反应(BALB/c反应细胞和C57B1/6刺激细胞)中,并测量胸腺嘧啶核苷掺入量。来自正常角膜和大疱性角膜病变角膜的培养上清液达到了相似水平的混合淋巴细胞反应抑制,添加抗转化生长因子-β2抗体或吲哚美辛均无法阻断这种抑制。来自正常眼睛和含有后段黑色素瘤眼睛的培养I/CB细胞的上清液在免疫抑制作用方面没有差异。添加吲哚美辛可部分阻断I/CB细胞上清液的混合淋巴细胞反应抑制作用。我们得出结论,正常和病理性角膜以及I/CB细胞都会产生混合淋巴细胞反应抑制因子,但这些组织的上清液通过不同方式发挥作用。角膜和I/CB组织产生免疫抑制因子的能力可能有助于人体原位角膜移植的成功。